Wordt geladen...
Insights into implementation of sacubitril/valsartan into clinical practice
BACKGROUND: Sacubitril/valsartan significantly reduced heart failure hospitalization and mortality in PARADIGM‐HF (Prospective Comparison of Angiotensin Receptor‐Neprilysin Inhibitor With an Angiotensin‐Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failur...
Bewaard in:
| Gepubliceerd in: | ESC Heart Fail |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933963/ https://ncbi.nlm.nih.gov/pubmed/29464879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12258 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|